GPs mainly provide exercise advice if it will help reduce the health complaint General Practitioners (GPs) mainly give their patients advice to engage in physical activity when exercise can reduce health complaints.
Nearly one-quarter of the Dutch population suffers from complaints or disorders of the digestive system Nearly 1 in 4 people in the Netherlands were registered at their general practitioner in 2017 with stomach, bowel or liver problems. This involves more than 3.7 million people.
Updated immunisation recommendation for measles: early vaccination before travel A number of European countries are currently seeing outbreaks of measles. Before the start of the summer season, RIVM has therefore updated its immunisation recommendation for measles.
No further spread of polio virus after contamination employee The employee of a Dutch vaccine manufacturer, who was infected with the polio virus in early April, is no longer carrying the virus.
Blood analysis local residents confirms longtime exposure to PFOA The results of blood analysis show that measured blood values correspond well with the calculated values in an earlier study in 2016 on the emission of perfluorooctanoic acid (PFOA) by DuPont/Chemo
HPV vaccination not only protects against cervical cancer HPV vaccination against cervical cancer also appears to protect against other forms of cancer that can be caused by HPV.
More knowledge required about environmental effect of GenX More knowledge is required about the extent to which GenX substances accumulate in fish.
Meningococcal immunisation recommendations re-examined Meningococcal disease is a very serious infectious disease that can cause meningitis or blood poisoning. Children are immunised against meningococcal serogroup C at 14 months.
Employee vaccine manufacturer infected with polio virus Early April, a sealed room at a vaccine manufacturer was the site of an incident. Two employees were exposed to the polio virus.
Benefits and bottlenecks for early marketing authorisation of new medicines Patients are asking increasingly often for quicker access to new, innovative medicines. This requires a more effective use of flexible marketing authorisation procedures.